Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

479

HTML

5086

Figures (1-3)

241

Tables (1-3)

160

Sum=5966

Dec 7, 2011 (publication date) through May 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 7, 2011; 17(45): 4952-4959
Published online Dec 7, 2011. doi: 10.3748/wjg.v17.i45.4952

Table 2 Local tumor progression rates of percutaneous ablation guided by contrast-enhanced ultrasound for hepatocellular carcinoma

HCC: Hepatocellular carcinoma; ND: Not described; PEI: Percutaneous ethanol injection; RFA: Radiofrequency ablation.

Citation: Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011; 17(45): 4952-4959
URL: https://www.wjgnet.com/1007-9327/full/v17/i45/4952.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i45.4952